Toronto-based BenchSci, which helps pharmaceutical firms accelerate R&D using AI, has announced $95 million CAD in Series D funding.| BetaKit
ProteinQure to debut AI-engineered cancer drug in the clinic, while AssistIQ expands medical supply platform.| BetaKit